Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Capital/Financing Update 2019

Apr 30, 2019

60656_rns_2019-04-30_89bd7174-9623-479a-bec1-b0f201872062.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

April 30, 2019

The manager- Listing BSE Limited Corporate Relationship Dept., 1 51 Floor, New Trading Ring Rotunda Buiding, P J Towers, Dalal Street, Fort, Mumbai 400001

National Stock Exchange of India Ltd. Exchange plaza, 5'11 Floor, Plot No.C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir,

Sub: SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018- Fund raising by issuance of Debt Securities by Large Entities

We wish to inform you that AstraZeneca Pharma India Limited does not fall under Large Corporate criteria as mentioned in the para 2.2 of the above mentioned SEBI Circular.

This is for your information and record.

Yours faithfully, For AstraZeneca Pharma India Limited

CORPORATE & REGD. OFFICE AstraZeneca Pharma-lndia Ltd. P. B. No. 4525, Block N1, 121h Floor, Manyala Embassy Business Park, Rachenahalli, Ouler Ring Road, Bangalore - 560 045, INDIA

TEL : +91 80 6774 8000 FAX : +91 80 6774 8857 CIN : L24231KA1979PLC003563 WEB : www.astrazeneca.com/indla FACTORY 12th Mile on Bellary Road Venkatala, Kattigenahalli Village Yelahanka Bangalore - 560 063 INDIA

TEL : +91 80 6774 9000

FAX : +91 80 2846 2208 +91 80 6774 9628